In areas exhibiting only weak staining of glutamine (median score = 1), the tumoral expression of MCT1 was much greater (median score = 3), whereas MCT4 expression (Figure 2C) was not different between glutamine-positive and -negative regions (median score = 2.75 and 2.5, respectively) on both tumor and stromal cells. The gene discussed is SLC16A3; the disease is neoplasm.